NCT04390152: Safety and Efficacy of Intravenous Wharton's Jelly Derived Mesenchymal Stem Cells in Acute Respiratory Distress Syndrome Due to COVID 19
- State
- Stopped early
- Phase
- Phase 1 and Phase 2
- People
- 6 taking part
- Started
- 13 Jan 2020
- Primary completion
- 3 Mar 2022
- Arms
- Mesenchymal stem cell
- Results
- None posted
- 13 Jan 2020: Trial started
- 15 May 2020: Trial registered
- 3 Mar 2022: Trial terminated